Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.
Mariano ProvencioAna RoyuelaMaría TorrenteMarina PollánJosé Gómez-CodinaPilar SabínMarta LlanosJosep GumáCristina QueroAna BlascoDavid AguiarFrancisco Ramón García-ArroyoJavier LaverniaNatividad MartínezManuel MoralesÁlvaro Saenz-CusiDelvys RodríguezVirginia CalvoLuis de la Cruz-MerinoMiguel Ángel de la CruzAntonio Ruedanull nullPublished in: Cancer (2017)
EFS12 and EFS24 predict an early increase in mortality. The long-term SMR, over the course of 10 years of follow-up, shows that patients with FL have a risk of dying similar to that of a sex- and age-matched general population. Cancer 2017;123:3709-3716. © 2017 American Cancer Society.
Keyphrases
- papillary thyroid
- free survival
- end stage renal disease
- palliative care
- cardiovascular events
- squamous cell
- chronic kidney disease
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- risk factors
- prognostic factors
- squamous cell carcinoma
- type diabetes
- cardiovascular disease
- patient reported outcomes
- patient reported